Joel Ackerman Davita Inc. (DVA) insider trading activity

Joel Ackerman is CFO and Treasuer of DAVITA INC.. Currently has a direct ownership of 127,454 shares of DVA, which is worth approximately $21.1 Million. The most recent transaction as insider was on Sep 16, 2024, when has been sold 21,602 shares (Common Stock) at a price of $163.56 per share, resulting in proceeds of $3,533,223. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 127K

27.38% 3M change

3.01% 12M change

Total Value Held $21.1 Million

JOEL ACKERMAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 16 2024	SELL Payment of exercise price or tax liability	$3,533,223 $163.56 p/Share	21,602 Reduced 14.49%	127,454 Common Stock
Sep 16 2024	SELL Sale (or disposition) back to the issuer	$6,000,035 $163.56 p/Share	36,684 Reduced 19.75%	149,056 Common Stock
Sep 16 2024	BUY Exercise of conversion of derivative security	$5,999,974 $75.95 p/Share	78,999 Added 29.84%	185,740 Common Stock
Aug 28 2024	SELL Open market or private sale	$734,794 $155.02 p/Share	4,740 Reduced 4.25%	106,741 Common Stock
Aug 27 2024	SELL Open market or private sale	$9,928,336 $155.06 p/Share	64,029 Reduced 36.48%	111,481 Common Stock
Mar 15 2024	SELL Payment of exercise price or tax liability	$1,096,704 $136.0 p/Share	8,064 Reduced 4.39%	175,510 Common Stock
Mar 15 2024	BUY Grant, award, or other acquisition	-	10,977 Added 5.64%	183,574 Common Stock
Mar 14 2024	BUY Grant, award, or other acquisition	-	15,794 Added 8.38%	172,597 Common Stock
Mar 06 2024	SELL Payment of exercise price or tax liability	$2,309,112 $134.65 p/Share	17,149 Reduced 9.86%	156,803 Common Stock
Mar 06 2024	SELL Sale (or disposition) back to the issuer	$2,882,587 $134.65 p/Share	21,408 Reduced 10.96%	173,952 Common Stock
Mar 06 2024	BUY Exercise of conversion of derivative security	$2,882,550 $52.41 p/Share	55,000 Added 21.97%	195,360 Common Stock
Feb 21 2024	SELL Sale (or disposition) back to the issuer	$2,882,628 $123.0 p/Share	23,436 Reduced 13.11%	155,290 Common Stock
Feb 21 2024	SELL Payment of exercise price or tax liability	$1,836,390 $123.0 p/Share	14,930 Reduced 9.61%	140,360 Common Stock
Feb 21 2024	BUY Exercise of conversion of derivative security	$2,882,550 $52.41 p/Share	55,000 Added 23.53%	178,726 Common Stock
May 15 2023	SELL Payment of exercise price or tax liability	$1,984,273 $96.86 p/Share	20,486 Reduced 14.21%	123,726 Common Stock
May 10 2023	SELL Payment of exercise price or tax liability	$989,674 $100.72 p/Share	9,826 Reduced 6.38%	144,212 Common Stock
May 10 2023	SELL Sale (or disposition) back to the issuer	$3,732,582 $100.72 p/Share	37,059 Reduced 19.39%	154,038 Common Stock
May 10 2023	BUY Exercise of conversion of derivative security	$3,732,524 $66.29 p/Share	56,306 Added 22.76%	191,097 Common Stock
Apr 04 2023	BUY Grant, award, or other acquisition	-	2,790 Added 2.03%	134,791 Common Stock
Mar 15 2023	SELL Payment of exercise price or tax liability	$377,842 $76.04 p/Share	4,969 Reduced 3.63%	132,001 Common Stock
Mar 15 2023	BUY Grant, award, or other acquisition	-	23,672 Added 14.74%	136,970 Common Stock
Mar 09 2023	BUY Grant, award, or other acquisition	-	1,387 Added 1.21%	113,298 Common Stock
Feb 23 2023	BUY Grant, award, or other acquisition	-	30,743 Added 21.55%	111,911 Common Stock
May 15 2022	SELL Payment of exercise price or tax liability	$3,401,200 $100.05 p/Share	33,995 Reduced 29.52%	81,168 Common Stock
Apr 19 2022	BUY Grant, award, or other acquisition	-	46,823 Added 28.91%	115,163 Common Stock

Also insider at

CSBR

CHAMPIONS ONCOLOGY, INC. Healthcare

Director

Joel Ackerman

CFO and Treasuer

Denver, CO

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DVA shares.

Notify only if

Value

Insider Trading

Get notified when an Davita Inc. insider buys or sells DVA shares.

Notify only if

Operation

Value

Type

News

Receive news related to DAVITA INC.

Track Activities on DVA

Account